Evidence map›Paper›PMID 34471945›Full record

ArticleCell and tissue banking2022

Novel technique of development of human derived acellular dermal matrix.

Felipe Salinas, David Robla, Álvaro Meana, Marta Pevida, Gonzalo Martinez Magide, Cristina Sánchez Nuño, Luis Martín Suárez, Aurora Astudillo González, Eva García, Luis Junquera

Abstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue banking, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Felipe SalinasDepartment of Plastic and Reconstructive Surgery, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain. fsalinasramila@gmail.com.ORCID http://orcid.org/0000-0001-5142-6149
David RoblaDepartment of Plastic and Reconstructive Surgery, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain.
Álvaro MeanaTissue Engineering Unit, Centro Comunitario Sangre y Tejidos de Asturias (CCST), Oviedo, Spain.
Marta PevidaTissue Engineering Unit, Centro Comunitario Sangre y Tejidos de Asturias (CCST), Oviedo, Spain.
Gonzalo Martinez MagideDepartment of Plastic and Reconstructive Surgery, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain.
Cristina Sánchez NuñoDepartment of Plastic and Reconstructive Surgery, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain.
Luis Martín SuárezDepartment of Plastic and Reconstructive Surgery, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain.
Aurora Astudillo GonzálezBiobank Asturias Principality, Oviedo, Spain.
Eva GarcíaTissue Engineering Unit, Centro Comunitario Sangre y Tejidos de Asturias (CCST), Oviedo, Spain.
Luis JunqueraDepartment of Maxillofacial Surgery. Hospital, Universitario Central de Asturias, Oviedo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reconstructive surgery techniques have evolved exponentially in last decades. From regional flaps to free tissue transfer, tissue movilization has become the gold standart treatment in many reconstructive procedures. Main disadvantage from these techniques lies in the possibility of sequels in donor zone. Furthermore, raising comorbidities in general population and growing indications for reconstructive surgery in elder people, have triggered the development of new biomaterials which can offer support in the reconstruction while elicit donor zone morbidity. Advances in tissue decellularization techniques have brought numerous matrices which have shown effectivity in many reconstructive procedures. Use of acellular dermal matrices may become an eligible solution for many reconstructive procedures. From breast reconstruction assisted by matrices to complex wound coverage passing throught tendon repair techniques, acellular dermal matrices have shown effectiveness in last studies. Local production of this biomaterial leads to cost minimization derived from harvesting and manufacturing matrices in our centre and avoid out-of-stock and storage issues. Current original protocol proposed by our group include all steps from harvesting samples from cadaveric donors till matrix storage after decellularization proccess. The result is a high valued biomaterial in terms of biocompatibility and security profile available.

Indexed as

Acellular DermisMammaplastyAgedBiocompatible MaterialsHumansWound HealingBiocompatible MaterialsAcellularDecellularizationDermalMatrixReconstruction

Identifiers

PMID34471945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.